GlassScriptPhysician profile
Jordan Brignac
NPI 1528410594
$4,007.37
in general payments reported to CMS, 2019-2025
32 companies · $754 in 2025
The $754 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $686 · 2022: $920 · 2023: $890 · 2024: $757 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,301 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,300.99 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,367.00 | 2021-2025 | |
| Glaxosmithkline, LLC. | $858.97 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $441.54 | 2021-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $184.52 | 2022-2025 | Freestyle Libre 3 |
| Pfizer INC. | $140.28 | 2021-2025 | |
| Novo Nordisk INC | $137.76 | 2021-2023 | Wegovy, Saxenda |
| Janssen Pharmaceuticals, INC | $117.90 | 2022 | |
| Jazz Pharmaceuticals INC. | $105.83 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.61 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.39 | 2021-2022 | |
| Merz North America, INC. | $42.95 | 2025 | |
| Phathom Pharmaceuticals, INC. | $39.27 | 2023-2024 | Voquezna |
| Almatica Pharma LLC | $35.00 | 2022-2023 | Loreev Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.72 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $31.43 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $29.86 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Eisai INC. | $29.73 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $29.15 | 2021-2022 | |
| Amgen INC. | $28.47 | 2023-2025 | Otezla, Repatha, Otezla |
| Lilly USA, LLC | $26.91 | 2022-2024 | Zepbound, Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $24.96 | 2022 | |
| Corium, LLC | $21.91 | 2023 | Azstarys |
| Vanda Pharmaceuticals INC. | $20.73 | 2025 | Fanapt |
| Astrazeneca Pharmaceuticals LP | $17.90 | 2025 | Airsupra |
| E.R. Squibb & Sons, L.L.C. | $17.65 | 2024 | Eliquis |
| Merck Sharp & Dohme LLC | $16.03 | 2021 | |
| Amarin Pharma, INC. | $15.46 | 2021 | |
| Supernus Pharmaceuticals, INC. | $14.88 | 2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $14.86 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.78 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.09 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $12.83 | 2023 | Nuedexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Brignac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.